Rates of Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses Increase
From 2010 to 2017, there were significant increases in the estimated rates of neonatal abstinence syndrome and maternal opioid-related diagnoses.
Pregnancy
Opioids and Psychotropic Medication Frequently Coprescribed During Pregnancy
Opioid coprescription with psychotropic medications during pregnancy increases a woman’s antepartum hospitalization risk.
Self-Reported Prescription Opioid Use During Pregnancy
The CDC analyzed prescription opioid use during pregnancy via a self-reported survey.
Managing Migraine During Pregnancy and Lactation
A particular challenge in this population is the effective management of migraine during pregnancy and lactation while minimizing the risk for harm to the fetus.
The Impact of Prenatal Opioid Exposure on Cognitive, Motor Development
Prenatal opioid exposure may be associated with poorer cognitive and motor development in children from age 6 months to adolescence.
Managing Migraine During Pregnancy and Lactation
A particular challenge in this population is the effective management of migraine during pregnancy and lactation while minimizing the risk for harm to the fetus.
Adverse Outcomes Up for Pregnant Women With Migraine
Increased risk for several neonatal, postnatal outcomes for offspring exposed to maternal migraine
Migraines in Pregnancy Tied to Worse Outcomes for Mother, Baby
Migraines in pregnant women are associated with an increased risk for pregnancy-associated hypertension disorders as well as an increased risk for a variety of adverse outcomes in the newborn.
Shared Decision-Making Tool Helps Pregnant Women With Opioid Use Disorder
Investigators aimed to determine the number of women who came to a treatment decision using the shared decision-making tool.
Pregnancy-Associated Mortality Involving Opioids Up
From 2007 to 2016, there was a sharp increase in pregnancy-associated mortality involving opioids.
-
Loading...
-
Loading...
Next post in Opioid Addiction
